Logo image of FTRC.CA

FUTR CORP/THE (FTRC.CA) Stock Fundamental Analysis

TSX-V:FTRC - TSX Venture Exchange - CA3609521057 - Common Stock - Currency: CAD

0.32  +0.02 (+6.67%)

Fundamental Rating

0

Overall FTRC gets a fundamental rating of 0 out of 10. We evaluated FTRC against 0 industry peers in the Unkown industry. Both the profitability and financial health of FTRC have multiple concerns. FTRC is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year FTRC has reported negative net income.
FTRC had a negative operating cash flow in the past year.
FTRC.CA Yearly Net Income VS EBIT VS OCF VS FCFFTRC.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

Industry RankSector Rank
ROA -42.24%
ROE N/A
ROIC N/A
ROA(3y)-142.63%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FTRC.CA Yearly ROA, ROE, ROICFTRC.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 500 1K

1.3 Margins

FTRC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 90.48%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FTRC.CA Yearly Profit, Operating, Gross MarginsFTRC.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 -100 -200

0

2. Health

2.1 Basic Checks

FTRC does not have a ROIC to compare to the WACC, probably because it is not profitable.
FTRC has about the same amout of shares outstanding than it did 1 year ago.
FTRC has a worse debt/assets ratio than last year.
FTRC.CA Yearly Shares OutstandingFTRC.CA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 20M 40M 60M
FTRC.CA Yearly Total Debt VS Total AssetsFTRC.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 1M 2M 3M 4M 5M

2.2 Solvency

FTRC has an Altman-Z score of -6.41. This is a bad value and indicates that FTRC is not financially healthy and even has some risk of bankruptcy.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -6.41
ROIC/WACCN/A
WACC8.2%
FTRC.CA Yearly LT Debt VS Equity VS FCFFTRC.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 -2M -4M -6M

2.3 Liquidity

FTRC has a Current Ratio of 0.44. This is a bad value and indicates that FTRC is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.44 indicates that FTRC may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.44
Quick Ratio 0.44
FTRC.CA Yearly Current Assets VS Current LiabilitesFTRC.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2M 4M 6M 8M

1

3. Growth

3.1 Past

FTRC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 39.17%, which is quite impressive.
Looking at the last year, FTRC shows a very strong growth in Revenue. The Revenue has grown by 25.01%.
EPS 1Y (TTM)39.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.14%
Revenue 1Y (TTM)25.01%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-40.78%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FTRC.CA Yearly Revenue VS EstimatesFTRC.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2M 4M 6M

0

4. Valuation

4.1 Price/Earnings Ratio

FTRC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FTRC.CA Price Earnings VS Forward Price EarningsFTRC.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FTRC.CA Per share dataFTRC.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1 -0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

FTRC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

FUTR CORP/THE

TSX-V:FTRC (5/14/2025, 7:00:00 PM)

0.32

+0.02 (+6.67%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)02-26 2025-02-26
Earnings (Next)05-28 2025-05-28
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners7.64%
Ins Owner ChangeN/A
Market Cap21.42M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.68
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0.12
BVpS-0.11
TBVpS-0.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -42.24%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 90.48%
FCFM N/A
ROA(3y)-142.63%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover1.49
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 171.86%
Cap/Sales 4.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.44
Quick Ratio 0.44
Altman-Z -6.41
F-Score5
WACC8.2%
ROIC/WACCN/A
Cap/Depr(3y)136.76%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.75%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.14%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)25.01%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-40.78%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y32.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-273.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-523.73%
OCF growth 3YN/A
OCF growth 5YN/A